News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Mark Terry

news@biospace.com

BioSpace News - By Mark Terry
Amgen (AMGN) Remains Hush-Hush Over FDA Rejection of Parsabiv 8/25/2016
How Pfizer (PFE)’s Antibiotics Buy from AstraZeneca PLC (AZN) Will Affect Jobs in the U.S. 8/25/2016
Medivation (MDVN) Exec Jumps Ship to Become CMO at BeiGene (BGNE) 8/25/2016
These Biotech Employers Hired the Most New Grads In Life Sciences 8/25/2016
Led by Former Genentech (RHHBY) Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships 8/25/2016
Just Days after a $14 Billion Medivation (MDVN) Buy, Pfizer (PFE) Buys AstraZeneca PLC (AZN)'s Antibiotics Business for $1.5 Billion-Plus 8/24/2016
3 High-Risk, High-Reward Biotech Stocks 8/24/2016
Bay Area's AllCells to Open Up Shop in Boston 8/24/2016
Celgene (CELG)'s Once-Nightmare Drug Turned Blockbuster Returns 8/24/2016
Affiliate of Amethyst Tech, Advent Laboratories, to Move to Western Maryland and Create 20 Jobs 8/24/2016
A Look at the Winners and Losers of Medivation (MDVN)'s $14 Billion Pfizer (PFE) Buyout Deal 8/23/2016
6 Hot Biotech Acquisition Targets 8/23/2016
SoCal's Sophiris Bio (SPHS) Evaluating Options, Will Not Pursue New Clinical Trials Unless New Financing is Obtained 8/23/2016
Pfizer (PFE) Scoops Sanofi (SNY) With $14 Billion Buyout Deal for Medivation (MDVN) 8/23/2016
Bayer (BAY) and CRISPR Form 80 Employee Joint Venture Named Casebia Therapeutics in Boston Area 8/22/2016
Active Pharmaceutical Ingredient Maker Lonza Biologics (LONN.VX) to Hire 70 in New Hampshire 8/22/2016
After Kendall Square Success, Alexandria Real Estate Equities Aims to Create Another Biotech Mecca in Massachusetts 8/22/2016
3 CEOs With the Biggest Golden Parachutes in Life Science 8/19/2016
Sarepta (SRPT)’s Duchene Muscular Dystrophy Drug: Evaluating the Placebo Effect 8/19/2016
Bay Area's Portola (PTLA) Plummets as FDA Rejects AndexXa NDA 8/19/2016
Google (GOOG)'s Calico Hires Another Big Name in Quest to Unlock Healthy Aging 8/19/2016
Merck & Co. (MRK)'s Sale of Legacy Products in India Hints at Restructuring 8/18/2016
StemCells (STEM) CEO, CFO and Three Directors Stepped Down the Day of Microbot Merger That Boosted Stock Sevenfold 8/18/2016
Cincinnati CRO CTI - Clinical Trial and Consulting Services Moves HQ to Kentucky and Promises 500 New Jobs over 12 Years 8/17/2016
Activist Investor Jeffrey Smith Wants to Overturn Depomed (DEPO) Board and Run it Like Olive Garden 8/17/2016
Former BIND Therapeutics (BIND) CEO Joins Agios (AGIO) as New CFO 8/17/2016
4 Cheap Biotech Stocks Ready to Fly 8/16/2016
A Gilead (GILD) and Bristol-Myers Squibb (BMY) Merger—Let Us Count the Ways 8/16/2016
Tioma, Originally Founded as Vasculox, Scores $86 Million Series A Financing 8/16/2016
Anavex (AVXL)'s Puzzling Business Problems 8/16/2016
Billionaire Hedge Fund Manager Increases Stake in Allergan (AGN), Cuts Back on Energy Bets 8/16/2016
As Baxalta (BXLT) Merger Closes, Shire (SHPG) Talks Job Cuts Worth $700 Million 8/15/2016
Up-and-Coming AxoSim Hiring Scientists After Landing Research Grants to Speed Research 8/15/2016
Pfizer (PFE) Goes Full Steam Ahead With Its Acquire-to-Expand Strategy, Big Buy Could Prevent a Split 8/15/2016
Serial Biotech Entrepreneur Raises Money to Launch New Startup DMD Therapeutics 8/15/2016
Apples to Apples: Comparing EXACT Sciences (EXAS) to Myriad Genetics (MYGN) 8/15/2016
Biotech Startup Practichem Is Buying Tesla Cars for Its Employees 8/15/2016
Radius Health (RDUS) May Be Acquisition Target for Shire (SHPG) Based on Its Osteoporosis Pipeline 8/12/2016
6 Biopharma Stocks Under $10 Per Share Expected to Climb 8/12/2016
AbSci’s Change in Strategy Scuttles Vancouver’s Plans for a Biotech Hub 8/12/2016
After a Dazzling Second Quarter, Amgen (AMGN) Develops Strategy to Deal With Upcoming Biosimilar Competition 8/11/2016
Allergan (AGN) to Consolidate Four New Jersey Locations Into One New U.S. HQ in Madison; PsychoGenics Also Moving In 8/11/2016
3 High-Risk, Potentially High-Reward Biotech Stocks 8/11/2016
French Government Denies Cover-Up of Birth Defects Study Related to Sanofi (SNY) Epilepsy Drug 8/11/2016
12-Employee Lexington Biotech, Aldeyra (ALDX) Shows Off Positive Drug Trial Data 8/10/2016
Allergan (AGN)'s Brent Saunders Denies Interest in Biogen (BIIB) or Big M&A 8/10/2016
Takeover Rumors Swirl Again as AstraZeneca PLC (AZN) Stock Hits Pfizer (PFE)'s 2014 Bid Price 8/9/2016
New York City Struggles To Compete With Cambridge and Bay Area for Life Science Startup Support 8/9/2016
Paul Singer’s Hedge Fund Sues AbbVie (ABBV) Over Failed 2014 Shire (SHPG) Merger 8/9/2016
San Diego's MEI Pharma (MEIP) Bags Cancer Deal Worth $464 Million With Helsinn 8/9/2016
Momenta (MNTA) Stock Jumps at Good News/Bad News—Buyout Rumors and Failed Trial 8/8/2016
Valeant (VRX)'s Constipation Drug Relistor Attracts Interest From Rivals, Sale Could Bring In $400-$500 Million 8/8/2016
Sarepta (SRPT) Stock Surges After Government Website Indicates Firm is Recruiting for Phase III Study 8/5/2016
Despite Skepticism, Biogen (BIIB) Stock Explodes After Merck & Co. (MRK) and Allergan (AGN) Takeover Speculation 8/5/2016
4 Biotech Stocks That Could Triple In Value This Year 8/4/2016
Biogen (BIIB) Not Pursuing an Acquisition, Says Source 8/4/2016
Shire (SHPG) Kills Baxalta (BXLT)'s Hemophilia B Program; Clears Path for BioMarin (BMRN), Spark Therapeutics (ONCE) and uniQure (QURE) 8/4/2016
Pfizer (PFE) Boss Won't Commit to a Company Split, But Decision Might Depend on Whether Clinton or Trump Wins the U.S. Presidential Election 8/3/2016
Speculation Heats Up on Whether a Spin-Off Could be in Gilead (GILD)'s Future 8/3/2016
4 Life Science CEOs Whose Track Records Make All the Difference 8/3/2016
Mass. Startup AVROBIO Rakes in $25 Million Series A to Push Two Gene Therapy Clinical Trials 8/2/2016
AstraZeneca PLC (AZN) CEO Stays Mum as Rumors Swirl Over a Possible Novartis AG (NVS) Takeover Bid 8/2/2016
How BioMarin (BMRN)'s Model for Super-Rare Diseases Made It a $15 Billion Powerhouse 7/29/2016
A Look at Four Biotech Giants' Q2 Earnings 7/29/2016
Brexit Schmexit: What This Mess Means for Life Science Jobs 7/29/2016
AstraZeneca PLC (AZN) Kills Six Pipeline Programs 7/28/2016
Pfizer (PFE) Wins Bid; Buys BIND Therapeutics (BIND) Bankruptcy Assets for $40 Million 7/27/2016
Flushed With Cash, Moderna Expands Space, Went on Hiring Spree and Launches at Least Two Clinical Trials 7/27/2016
Post-Brexit, GlaxoSmithKline (GSK) Eyes Jobs Boost With $360 Million Investment in Three UK Manufacturing Sites 7/27/2016
Why Investors are Still Throwing Cash at Debt-Ridden Kadmon, a NYC Biotech Founded By Ex-Con Sam Waksal 7/26/2016
Speculation Heats Up on Biogen (BIIB) as an Acquisition Target or Starting a Buying Spree 7/26/2016
pSivida (PSDV) Has Its Own Brexit, Consolidates U.K. Operations to Massachusetts HQ 7/26/2016
Bankrupt BIND Therapeutics (BIND) Reveals Two More Bidders Join Pfizer (PFE)'s Stalking Horse Bid 7/26/2016
5 Biotech Stocks on the Brink of Breaking Out 7/25/2016
As Biogen (BIIB) Boss Moves to the Bay Area, California Biotechs Pay Attention 7/25/2016
A Look at Who Could Buy Gilead (GILD) and Who Gilead Should Buy 7/25/2016
3 Battered Biopharma Stocks Battling to Recover 7/22/2016
Biogen (BIIB) CEO Steps Down Amid Stellar Q2 Financials, Hunt for New Leader Begins 7/22/2016
Why Investors Should Pay Attention to Seattle Genetics (SGEN)' Drug Trial 7/22/2016
Amid Trial Concerns, FDA Delays Approval Decision for Merck & Co. (MRK)'s C. Diff Drug, New PDUFA Date Set 7/22/2016
Zafgen (ZFGN) Pinks Slips 34% of Workforce, Scraps Lead Obesity Drug After Deaths 7/21/2016
AstraZeneca PLC (AZN) Announces MedImmune (AZN) Layoffs, But Does Not Specify Numbers or Location 7/21/2016
Johnson & Johnson (JNJ)'s CFO Talks M&A Strategy, Doesn’t Rule Out Acquisitions 7/20/2016
Zafgen (ZFGN)'s Alicia Secor Steps Up as Juniper Pharma (JNP)’s President and CEO 7/20/2016
Cambridge Startup Jounce Lands $2.5 Billion Deal With Biotech's Best Friend Celgene (CELG) 7/20/2016
Former bluebird bio (BLUE) CSO Takes the Reins at Oncorus; Startup Launches with $57 Million Series A 7/20/2016
Bay Area's SciClone (SCLN) Abandons Sale Strategy 7/19/2016
Examining Pfizer (PFE)’s Strategic Options-Split Up or Start Buying 7/19/2016
Why 5 Big Pharma’s Struggle to Please Investors 7/19/2016
3 Biotech Stocks for the Conservative Investor 7/18/2016
Juno (JUNO) Stock Falls Again After Correcting Number of Trial Deaths 7/18/2016
ZIOPHARM Abandons $50 Million Stock Offering After Clinical Trial Deaths 7/18/2016
The ROI of Gratitude: Two Biotechs Getting It Right 7/18/2016
Merck & Co. (MRK) to Cut or Shift 360 East Coast Jobs, Add 100 in the Bay Area 7/15/2016
With a Strong Cancer Presence and Pipeline, Incyte (INCY) Would Make a Sweet Acquisition 7/15/2016
With Little Fanfare, Biogen (BIIB) Sneaks Lupus Drug Into a Phase I Trial 7/15/2016
Former Biogen (BIIB) Exec to Head Decibel Therapeutics, Plans to Fill 20 Jobs This Year, 40 to 60 in 2017 7/14/2016
Life Science Job Market in Washington State Heats Up as Juno (JUNO) and Seattle Genetics (SGEN) Hire 250+ 7/14/2016
Evaluation: 7 Biopharma Companies’ Market Value Based on Pipelines 7/14/2016
Juno (JUNO) Soars After the FDA OKs Restart of Clinical Trial 7/14/2016
Bay Area's Second Genome Taps New CEO, Series B Financing Expanded to $51 Million 7/14/2016
SAGE Therapeutics (SAGE)' Stock Explodes as Drug Eliminates Postpartum Depression in Mid-Stage Study 7/14/2016
Sanofi (SNY) Hunts Other Oncology Companies for Cancer Gold 7/13/2016
San Diego's Sorrento (SRNE) Forges €735 Million Immuno-Onco Tie-Up with Servier 7/12/2016
How Gilead (GILD) Is Built Like Apple (AAPL) 7/11/2016
As Shire (SHPG) Closes on Baxalta (BXLT), David Meek Takes the Helm at Ipsen (IPN.PA) 7/11/2016
Japan's Nichi-Iko Takes Out Sagent Pharma for $736 Million Cash 7/11/2016
Juno (JUNO) Halts CAR-T Cancer Trial After Three Patient Deaths 7/11/2016
Pfizer (PFE) Stock Climbs With Positive Renal Cancer Phase III Data 7/8/2016
Pernix (PTX) Axes 23% of Workforce in Restructuring to Save $10 Million Annually 7/7/2016
Cempra (CEMP) Stashes Cash to Focus on Marketing Its New Anti-Bacterial Once FDA Gives It Thumb’s-Up 7/7/2016
Scancell (SCNLF) Delays Melanoma Trial 9 to 12 Months to Whip Up New Batch of Cancer Vaccine 7/7/2016
Gilead (GILD)'s Strategy for New Hep C Drug Epclusa 7/7/2016
With Jobs at Stake, Medivation (MDVN) Inks Confidentiality Deals With Sanofi (SNY), Pfizer (PFE) and Celgene (CELG) 7/6/2016
Bristol-Myers Squibb (BMY) Scoops Up Swedish Firm Cormorant in $520 Million Deal 7/6/2016
Arena (ARNA) Drops Bombshell on its Workforce by Cutting 73% of Jobs 7/6/2016
TiGenix Lands $400 Million+ Crohn's Disease Deal with Pharma Giant Takeda (TKPYY) 7/6/2016
This Year’s Top 10 Disappointing Clinical Trials—So Far! 7/6/2016
Vertex (VRTX) and Moderna Hammer Out $315 Million+ Deal to Treat Cystic Fibrosis Using mRNA Technology 7/6/2016
Only Days After Inking Asset Swap Deal With Sanofi (SNY), Boehringer Ingelheim Cuts 725 Jobs in the U.S. 7/5/2016
Tesaro (TSRO) Stock Soars as Acquisition Rumors Swirl After Excellent Phase III Results 7/5/2016
AstraZeneca PLC (AZN), Valeant (VRX) and LEO Pharma Shuffle Dermatology Rights, Potential $1 Billion in Sales at Stake 7/5/2016
3 Biopharma Stocks That Have Taken a Lickin & Kept on Tickin 7/1/2016
Check Out These 3 Solid Biotech Stocks That Are Currently Undervalued 7/1/2016
Fibrocell (FCSC) Looking for Azficel-T Buyer and Lays Off Employees as Program Winds Down 7/1/2016
With Investments from Pfizer (PFE) and AbbVie (ABBV), Morphic Therapeutic Closes a $51.5 Million Series A Round 7/1/2016
3 Bargain Basement Biotech Stocks That Have the Potential to Skyrocket 6/30/2016
Infinity Pharma (INFI) Cuts Jobs by 58% as AbbVie (ABBV) Terminates Duvelisib Collaboration Deal 6/30/2016
As Stock Rises and Baxalta (BXLT) Merger Closes, Shire (SHPG) Opens New HQ in Massachusetts with 800 Jobs 6/30/2016
Investors Gain Focus as Shire (SHPG) Stock Rises at Positive ADHD Drug News 6/30/2016
How Amgen (AMGN) Fits Into Pfizer (PFE)’s Restructuring Plans 6/30/2016
Israel’s Kaiima Bio-Agritech Ltd. Expands U.S. Operations in St. Louis 6/29/2016
In Light of Two Major Failed Trials, FORUM Pharma Closes Its Doors This Week 6/29/2016
CRO Veristat Plans Expansion in Research Triangle Area, To Hire 150 Or More Starting Now 6/29/2016
NewLink Genetics (NLNK) Stock Slides and Company Lays Off 87 After Failed Trial 6/28/2016
Biotech Startup Immage Biotherapeutics (IMMG) Gets Ready for Philadelphia Expansion 6/28/2016
Sanofi (SNY) Inks Deal to Swap Business with Boehringer Ingelheim 6/28/2016
Mayne Pharma Expands into U.S. Through the $652 Million Acquisition of 42 Generic Drugs From Allergan (AGN) and Teva (TEVA) 6/28/2016
Bristol-Myers Squibb (BMY)'s Miracle Drug Opdivo Receives Yet Another Breakthrough Designation 6/28/2016
How Brexit Is Affecting UK’s Drug Companies, Including GlaxoSmithKline (GSK), Gilead (GILD) and AstraZeneca PLC (AZN) 6/28/2016
Pfizer (PFE)’s $200 Million Facility in Massachusetts Will Create 75 Permanent Jobs 6/22/2016
5 Biotech Stocks at Bargain Basement Prices 6/22/2016
Epizyme (EPZM) to Continue Blood Cancer Trials as Tumors Were Wiped Out in Some Patients 6/21/2016
Kite Pharma (KITE) and Juno (JUNO)'s R&D Strategy to Reshape Cancer Treatment 6/21/2016
Bay Area's IMPAX Labs (IPXL) Plunks Down $586 Million for a Chunk of Teva (TEVA) and Allergan (AGN)’s Generics Portfolio 6/21/2016
Selecta's IPO Expected Next Week; Sixth Biotech in Massachusetts to Go Public This Year 6/20/2016
As Monsanto  (MON) Bid Stalls, Bayer AG (BAYZF) Mulls Sale of $3 Billion Radiology Business 6/20/2016
4 Movers & Shakers in This Year’s Oncology Market 6/20/2016
Stock Pop Gives Hints that GlobeImmune (GBIM) Might Be Fielding Takeover Offers 6/20/2016
If Spurned By Medivation (MDVN), Sanofi (SNY) May Turn to BioMarin (BMRN) for a Little Love 6/17/2016
Pfizer (PFE) Head of R&D Talks Strategy on How Pharma Chooses Compounds to Bet A Billion Dollars On 6/16/2016
Inside the Biotech Employer's Head: Job Interview Questions That You Should Be Ready to Answer 6/16/2016
3 Battered and Bruised Life Science Stocks Ready for a Comeback 6/16/2016
Perrigo (PRGO) Stock Spikes on Rumors of Mystery UK Company’s $20 Billion Acquisition Bid 6/15/2016
Once Floated as Allergan (AGN) Target, Revance (RVNC)'s Stock Drops as Crow’s Feet Drug Fails Trial 6/14/2016
Looking at the Odds, Pfizer (PFE), Incyte (INCY) or Merck & Co. (MRK) Will Gobble Up Tiny Agenus (AGEN) 6/14/2016
Bay Area's diaDexus Files Chapter 7 Bankruptcy, Plans to Liquidate Assets, CFO to Step Down Immediately 6/14/2016
Amid Insider Trader Investigations, Acucela (AUCL) and Otsuka Pharma Kill Glaucoma Drug Deal After Failed Trial 6/14/2016
Unclear Whether FDA Took Into Account KemPharm (KMPH)'s Amendment Data in Rejecting Apadaz Application 6/14/2016
5 Biotech Stocks for Investors Who Want Long-Term Returns 6/13/2016
Sam Waksal, Part of the Martha Stewart Insider Trading Scandal, Exits Kadmon as Company Files for $115 Million IPO 6/13/2016
3 Life Science Stocks Millennials Should Watch Over the Long Haul 6/10/2016
Amid Plunging Stocks and Failed Trials, Biogen (BIIB)’s CIO Quietly Leaves Company 6/10/2016
Days After Judge Overturns Merck & Co. (MRK)-Gilead (GILD) Lawsuit, Merck Acquires Bay Area's Afferent Pharma for $1.2 Billion 6/10/2016
Amgen (AMGN) Shows Off Mid-Stage Migraine Data, Needs to Compete With Eli Lilly (LLY), Teva (TEVA) and Alder Biopharma 6/9/2016
BIO2016: The State of the Biotech Innovation and Drivers of Forecasting Success 6/9/2016
Mologen (MOLGF.PK) Restructures, Pushes Immunology Program, Shelves Renal Cancer Vaccine 6/9/2016
Biogen (BIIB) Loses $8 Billion in Market Value in One Day After Failed Trial 6/8/2016
Rho's Mission to Headhunt for New Employees at DIA 2016 6/8/2016
BIO2016: Where the Bioscience Jobs Are and the Current Trends 6/8/2016
FDA Questions Merck & Co. (MRK)'s C. Diff Diarrhea Medication’s Efficacy 6/8/2016
Former Pfizer (PFE) Employee and Childhood Friend Busted on Insider Trading Scheme 6/7/2016
Allergan (AGN) CEO Dishes on Strategy and Some Of His Battles Over Deals And Mergers 6/7/2016
Sarepta (SRPT) Surges Yet Again, as the FDA Requests More Data About Duchenne’s Drug 6/7/2016
Former Medivation (MDVN) CMO Takes Helm at Roivant Sciences-Takeda (TKPYY)'s Newly Launched Company Myovant Sciences 6/6/2016
ASCO2016: AbbVie (ABBV) Pushes R&D, While Stemcentrx's Lung Cancer Drug Shows Early Promise 6/6/2016
ASCO2016: After NantHealth (NH) Explodes onto the Market, Patrick Soon-Shiong Prepares for Two More 6/6/2016
Rumors Floating Again that Roche (RHHBY) or GlaxoSmithKline (GSK) Might Acquire Bay Area’s Pacific Biosciences (PACB) 6/3/2016
Pfizer (PFE) Boss Discusses M&A Strategy and Says No to Tax Inversions 6/3/2016
Why Sanofi (SNY) is So Infatuated With the Bay Area’s Medivation (MDVN) 6/3/2016
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex (CLDX) Stock 6/3/2016
Patrick Soon-Shiong's NantHealth (NH) Explodes onto Market in IPO Debut 6/3/2016
Novartis AG (NVS) Employees in Shanghai Get a New $1 Billion Home 6/2/2016
All Eyes Turn to Sarepta (SRPT) as BioMarin (BMRN) Shutters Its Kyndrisa Duchenne Program 6/2/2016
Roche (RHHBY) and Novartis AG (NVS) Gear Up to Battle Over Biosimilars 6/2/2016
Activist Investor Carl Icahn's Big Buy of Allergan (AGN) Shares Raises Questions of Influence 6/1/2016
2 Potentially Hot Biotech Stocks Currently Under $5 Per Share 6/1/2016
Why Intercept Pharma (ICPT) Just Became an Even More Attractive Takeover Target 6/1/2016
Bad News for AstraZeneca PLC (AZN) is Good News for Relypsa (RLYP) 5/31/2016
Novartis AG (NVS) Trial Stopped Early on Positive Data, Gets Ready to Take on Pfizer (PFE)'s Ibrance 5/31/2016
Gilead (GILD), Biogen (BIIB), Jazz Pharma (JAZZ) Subpoenaed as Feds Investigate Drugmaker-Charity Connections 5/27/2016
3 Biotech Stocks Flying High Under-the-Radar 5/27/2016
FORUM Pharma CEO Quits Amid Layoffs and a Possible Company Shutdown 5/27/2016
Titan Pharma (TTNP) Receives FDA Approval for the First Ever Implantable Device for Opioid Dependency 5/27/2016
Making Sense of Alnylam (ALNY)’s Recent Stock Surge 5/27/2016
Nine Bay Area Biotechs Vie to be the “Next Genentech (RHHBY)” 5/26/2016
Sarepta (SRPT) Rockets After the FDA Delays Ruling on DMD Drug 5/26/2016
Serial BioPharma Entrepreneurial Team Launches Arrivo BioVentures with $49 Million 5/25/2016
Amid Restructuring and Lawsuits, Novartis AG (NVS) Indicates It Might Sell $14 Billion Roche (RHHBY) Stock Without a Premium 5/25/2016
Eli Lilly (LLY) Projects 20 New Product Launches in 10 Years with 20 Possible Expansions 5/25/2016



//-->